In the highly competitive market for inflammatory diseases such as Crohn's, pharma companies are looking for ways to maximise benefits of already approved drugs, as well as
UK biotech Futura Medical has said it will seek approval for its MED3000 topical treatment for erectile dysfunction in Europe, using a medical devices pathway.
Johnson & Johnson has announced it has expanded a collaboration with a US government agency to hasten development of its coronavirus vaccine, as fears mount about the scale of the outbr
